Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax with Pomalidomide and Dexamethasone in R/R Multiple Myeloma
NCT03567616Phase 2Terminated
- Sponsor
- AbbVie Inc.
- Start
- Oct 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of venetoclax in multiple myeloma (MM), sponsored by AbbVie Inc.. Started Oct 2018; status: terminated.
02
Drugs
venetoclax
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03567616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567616.